Latest News- Ursodeoxycholic Acid Market: Synthetic is expected to lead the Type segment during 2025-2029

The Ursodeoxycholic Acid Market is being driven by Rise in number of liver transplants

The Ursodeoxycholic Acid Market is expected to grow at a CAGR of 12.9% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 550.4 million. Ursodeoxycholic acid (UDCA), a bile acid, holds significant value in the therapeutic arena for managing various liver disorders and diseases, including Primary Biliary Cholangitis (PBC) and gallstone dissolution. The global ursodeoxycholic acid market is propelled by the increasing acceptance of combination therapies in the treatment of liver diseases. These therapies involve the concurrent administration of two or more medications to amplify treatment efficacy and optimize patient outcomes. In the realm of liver disorders, the synergistic use of UDCA with immunosuppressants or steroids has been clinically proven to retard disease progression and alleviate symptoms, thereby bolstering market growth. 

Get more information on Ursodeoxycholic Acid Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Synthetic
  • Extraction
• Application
  • Pharmacy products
  • Health products
• Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rise in number of liver transplants
• Increasing incidence of primary sclerosing cholangitis and associated diseases
• Expansion of indications for UDCA

However, the market also witnesses some limitations, which are as follows:

• Expiry of patents on branded drugs leading to competition with manufacturers of generics
• Adverse effects and safety concerns associated with UDCA
• Limited awareness and underdiagnosis of liver diseases

Benefits of Buying Global Ursodeoxycholic Acid Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Ursodeoxycholic Acid Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Ursodeoxycholic acid (UDCA) is a bile acid with therapeutic applications in various liver conditions. It promotes liver cell regeneration, enhances bile acid excretion, and hinders cirrhosis progression. UDCA offers hepatotoxicity prevention against drug-induced liver injury and non-alcoholic fatty liver disease. It reduces oxidative stress, inhibits apoptosis, and regulates bile flow. UDCA improves liver function, alleviating cholestatic jaundice and intrahepatic cholestasis. Nuclear receptors and liver regeneration pathways are involved, along with drug metabolism enzymes and lipid metabolism. UDCA interacts with hepatic stellate cells, inflammation markers, fibrosis markers, liver histology, serum markers, and clinical trial outcomes.

Market Research Overview

The Ursodeoxycholic Acid (UDCA) market is a significant segment of the global pharmaceuticals industry, focusing on the production and research and development of drugs used in bile acid metabolism, cholesterol gallstones treatment, and cholestasis management. According to Technavio, the global pharmaceuticals market is projected to expand due to several factors, including the increasing aging population. By 2050, approximately one-quarter of the US and European populations are predicted to be over 60 years old. This demographic shift will increase the demand for UDCA, as it is commonly used to treat gallstone disease and liver conditions prevalent in older adults. Additionally, UDCA's role in improving hepatic bile flow and managing cholestasis makes it a crucial medication in the healthcare sector. The global pharmaceuticals market size is calculated based on the combined revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/